NEWS

Noramco at AAPS 2018

Noramco is participating in the Scientific Thought Leadership program at this year’s AAPS. Dr. Wen-Chun Zhang will be presenting a Chalk Talk on the topic of “The New Era of Ultra-Pure Synthetic Cannabinoids” on Tuesday, November 6th, 2018 from 10:30 am to 10:50 am located in Learning Lounge 1, Exhibit Hall A/B.

To find out more please go to:

https://www.eventscribe.net/2018/PharmSci360/agenda.asp?startdate=11/6/2018&enddate=11/6/2018&BCFO=&tn=&cpf2=&cus2=&pta=&h=Tue,%20Nov%206               

Laura DeShullo and Joshua Hoerner will also be presenting a poster at the Poster Session on Tuesday, November 6th, 2018 from 10:30 am to 11:30 am. The topic will be “Evaluation and Prevention of an Unknown Impurity On-Column Formation in HPLC Impurity Analysis of an Active Pharmaceutical Ingredient”.

To find out more please go to:

https://www.eventscribe.net/2018/PharmSci360/PosterTitles.asp?goToLetter=E&pfp=PosterTitles

Visit us at AAPS, booth #2144, to find out more about the latest products and developments from Noramco.

Noramco is a specialty active pharmaceutical ingredient (API) company that develops and supplies pharmaceutical-grade cannabinoids, attention deficit hyperactivity disorder (ADHD), and addiction treatment and abuse prevention (ATAP) ingredients to pharmaceutical manufacturers. Offering comprehensive technical support and supply chain solutions, Noramco assists customers through all phases of pharmaceutical product development and commercial production.